CAMBRIDGE, Mass. (AP) _ InVivo Therapeutics Holdings Corp. (NVIV) on Tuesday reported a loss of $12.9 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of $7.48 per share.

In the final minutes of trading on Tuesday, the company's shares hit $2.08. A year ago, they were trading at $50.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NVIV at